We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BARR SAYS GENERIC BIOLOGICS SHOULD BE SUBSTITUTABLE
BARR SAYS GENERIC BIOLOGICS SHOULD BE SUBSTITUTABLE
June 29, 2004
Generic biologics can be developed using available raw materials, and the FDA can approve the products as fully substitutable for their brand equivalents, according to Barr Pharmaceuticals’ executives, who challenged some common perceptions about the complex molecules.